Emerging treatments

Plasmapheresis

Proposed as a treatment strategy in patients with a recent history of HIT who require cardiopulmonary bypass surgery, and in patients with active HIT who are not responding to standard therapy. The evidence to date consists of retrospective case reports.[66][67]

Intravenous immune globulin

Case reports suggest that high dose intravenous immune globulin can be considered for severe HIT that is refractory to standard treatments.[67]​[68]​​

Use of this content is subject to our disclaimer